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Identification of N-Terminal Lobe Motifs that Determine the Kinase
Activity of the Catalytic Domains and Regulatory Strategies of Src
and Csk Protein Tyrosine Kinases†
Kezhen Huang, Yue-Hao Wang, Alex Brown, and Gongqin Sun
From the Department of Cell and Molecular Biology, University of Rhode Island, Kingston, RI 02881
Abstract
Csk and Src protein tyrosine kinases are structurally homologous, but use opposite regulatory
strategies. The isolated catalytic domain of Csk is intrinsically inactive and is activated by interactions
with the regulatory SH3 and SH2 domains, while the isolated catalytic domain of Src is intrinsically
active and is suppressed by interactions with the regulatory SH3 and SH2 domains. The structural
basis for why one isolated catalytic domain is intrinsically active while the other is inactive is not
clear. In this current study, we identify the structural elements in the N-terminal lobe of the catalytic
domain that render the Src catalytic domain active. These structural elements include the α-helix C
region, a β-turn between the β-4 and β-5 strands, and an Arg residue at the beginning of the catalytic
domain. These three motifs interact with each other to activate the Src catalytic domain, but the
equivalent motifs in Csk directly interact with the regulatory domains that are important for Csk
activation. The Src motifs can be grafted to the Csk catalytic domain to obtain an active Csk catalytic
domain. These results, together with available Src and Csk tertiary structures, reveal an important
structural switch that determines the kinase activity of a catalytic domain and dictates the regulatory
strategy of a kinase.
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Protein tyrosine kinases (PTKs)1 are a large family of enzymes that catalyze the same chemical
reaction: phosphorylation of proteins on Tyr residues. Yet each PTK plays a specific role in
the signaling network of a mammalian cell. A key to the functional specificity of each kinase
is its ability to respond to different regulatory signals. Even though the regulatory mechanisms
in the kinome are highly variable, they can be classified into two general categories. Some
kinases contain intrinsically inactive catalytic domains, such as Csk (1,2) and Fps (3), and the
regulation of such kinases is based on the activation of the catalytic activity. Other kinases,
such as Src (6) and Abl (7–8), contain intrinsically active catalytic domains (4,5) and their
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regulation is often based on inactivation of the catalytic activity. Recent studies reveal that the
SH2 domain of Abl may also stimulate the kinase activity through interaction with the N-
terminal lobe of the catalytic domain (3). In all these scenarios, the intrinsic activity of the
catalytic domain is a central feature that dictates the regulatory strategy of a kinase.
Src and Csk are two protein tyrosine kinases that typify these opposite regulatory strategies,
even though they have a similar structural organization of SH3-SH2-catalytic domains. The
catalytic domain of Src alone is highly active (4,5), and the activity is suppressed by domain-
domain interactions when a C-terminal Tyr (Tyr527) is phosphorylated (9,10). This inactive
form is the predominant and basal form in most cells, and can be activated by several
mechanisms (11). For example, binding of the SH2 (12,13) or the SH3 domain (14,15) to
external ligands, autophosphorylation in the activation loop (on Tyr416) (16), or binding to an
activated α subunit of some G-proteins (17) can activate Src. In contrast, the catalytic domain
of Csk alone displays minimal kinase activity (1). Extensive interactions between the catalytic
domain and the regulatory SH3 and SH2 domains activate the catalytic activity (1,2,18–20).
Furthermore, the Csk SH2 domain can bind to the Csk-binding protein, which further activates
Csk activity (18,21,22). Thus the domain-domain interactions in Csk also serve as a basic
platform for Csk regulation, albeit in a way generally opposite to that in Src. The crystal
structures of Csk and Src family kinases reflect the two regulatory strategies. In full-length
Csk structure (23), the SH3 and SH2 domains are located on top of the catalytic domain, and
form direct interactions with residues from the N-terminal lobe of the catalytic domain. The
catalytic domain alone adopts a conformation typical for an inactivated kinase (24). Several
crystal structures of inactive Src and other Src family kinases (10,25,26) and one activated full-
length Src (27) are available, providing clues to how domain-domain interactions regulate Src
kinase activity.
A key question regarding kinase regulation that is yet to be answered is why some catalytic
domains are intrinsically active while others are intrinsically inactive. The catalytic domain of
a kinase contains two lobes, a smaller N-terminal lobe (N-lobe: about 80 aa) and a larger C-
terminal lobe (C-lobe: about 180 aa). The cleft between the two lobes contains the ATP-binding
site and harbors many catalytically essential residues (28). The C-lobe contains the motifs for
recognizing protein substrates (29–32). The N-lobe contains most of the residues in the ATP-
binding pocket and many of the catalytically essential residues, and is considered more
conserved among PTKs. However, two recent studies suggest that the N-lobe may contain
structural determinants that dictate the kinase activity of a catalytic domain. Using molecular
dynamics free energy calculations, Banavali and Roux (33) show that the N-terminal end of
the Hck catalytic domain contains a conformational switch implicated in long-range allosteric
regulation. A recent study (34) of Csk and Src chimeric kinases indicates that the N-lobe
dictates the kinase activity. Both studies implicate the N-lobe of the catalytic domain as the
key determinant for the regulatory strategy of a kinase.
In the current study, we performed mutagenic and grafting experiments to identify the structural
motifs that dictate the opposing regulatory mechanisms in Csk and Src family kinases. The
results demonstrate that the N-lobe of Src contains regulatory structural elements that enable
the catalytic domain to be intrinsically active, and such structural motifs can be grafted to the
Csk catalytic domain to result in an active Csk catalytic domain. These results provide insights
into the structural divergence in the N-lobes that dictates the regulatory strategy of kinases.
Results
Strategy for dissecting the regulatory architecture of Csk and Src
A central question in understanding the different regulatory mechanisms of Src and Csk is why
the Src catalytic domain is active while the Csk catalytic domain is inactive. A previous study
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(27) reveals that the N-lobe dictates the activity level of a catalytic domain. While the catalytic
domain of Csk has minimal kinase activity, a chimeric kinase composed of the Src N-lobe and
the Csk C-lobe has kinase activity comparable to that of the catalytic domain of Src. These
observations indicate that the Src N-lobe contains structural elements that render a catalytic
domain active.
Figure 1A shows a comparison between the amino acid sequences of the N-lobes of Csk and
Src. The N-lobe of a protein tyrosine kinase catalytic domain contains five β-strands, one α-
helix and several loops and turns connecting them. Shown in Figure 1B is the secondary
structure of Src N-lobe. To identify the activating structural motifs in the Src N-lobe, we
employed the following strategy. The inactive catalytic domain of Csk (C0) was used as the
basal form into which various portions of the Src N-lobe, individually or in combination, were
grafted to replace the Csk counterparts (Figure 2). Analysis of kinase activity of these chimeric
kinases helps locate the motifs of Src that would activate the Csk catalytic domain. When
appropriate, the identified motifs will be investigated further by more specific mutations on
the background of Src or Csk catalytic domains. By comparing and contrasting the activities
of various mutants, the role of specific motifs in regulating the kinase activity can be
deciphered. The ultimate goal is to identify the minimal structural elements from Src that can
activate the Csk catalytic domain and to understand the role of these motifs in the regulation
of Src and Csk.
Walking chimeras suggest motifs in the N-lobe that are crucial for regulation
The chimeric constructs of Csk catalytic domain containing various grafts of Src are illustrated
in Figure 2. Replacing various fragments of the Csk catalytic domain with the Src counterparts
resulted in recovery of different levels of kinase activity, and analysis of these mutants suggests
three regions of Src that are potentially important for activating a catalytic domain. Region 1
includes S248-E270 (based on Src numbering). A comparison between C6 and C7 in Figure
2 suggests that this region is crucial for the function of the Src N-lobe. Region 1 includes part
of the linker between the SH2 domain and the catalytic domain (S248-A259) and the beginning
portion of the catalytic domain that contains the highly conserved Trp residue (W260-E270).
The amino acid sequences in this region differ significantly between Csk and Src (Figure 1).
Region 2 is the fragment of T297-K316, which results in an increase of activity from 0.03
min−1 (C1) to 21 min−1 (C2). This region includes the α-helix C and a loop N-terminal to the
α-helix C (C-loop). The α-helix C is a crucial motif for kinase regulation, and its conformation
directly correlates to the activity of a catalytic domain (34). Region 3 is the fragment of Y326-
M341, which causes an increase in kinase activity from 20 to 170 min−1 (C3 versus C7). Region
3 contains parts of the β4 and β5 strands, and the turn between them (β-4.5 turn). The
identification of these regions may not be exhaustive and other portions of the N-lobe could
also contribute to the activation of a catalytic domain. However, this analysis provides clues
to the potentially important motifs for further analysis.
Region 3: β-4.5 turn is a major motif that differentiates Src and Csk regulation
There are several structural differences between Csk and Src in region 3. One difference is the
β-4.5 turn that has the sequence of SEEPI in Src and EEKGG in Csk. Both the β-4 and β-5
strands are also longer by one residue in Csk than in Src. In addition, two residues in Csk,
L252G, are replaced by Y326A in Src. To investigate the role of the β-4.5 turn region, these
structural features of Src were individually added into C2 to determine what structural features
are important for the kinase activation (Figures 3A and 3B). The Csk β-4.5 turn in C2 (EEKGG)
was first replaced by the counterpart of Src (SEEPI), however, this mutation resulted in a slight
decrease in the kinase activity (C2.1). This suggests that either the β-turn sequence is not
important or the correct sequence in the β-4.5 turn needs to be positioned correctly for it to
stimulate the kinase activity. We then deleted the residues I255 and L263 individually and in
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combination from C2.1 to test if shorter β-4 andβ-5 strands are important for the activation.
Deletion of I255 resulted in a recovery of activity from 13 min−1 to 16 min−1, while deletion
of L262 resulted in an increase to 25 min−1. When both residues were deleted, the mutant
displayed an activity of 310 min−1. These results indicate that the shorter β4 and β5 strands
are crucial for a functional Src N-lobe.
To confirm that the shorter β4 and β5 are indeed important for the activity of Src, two mutants
based on C7 were generated, inserting a single residue, Ile after V329, (C7+I330) or Leu after
I335 (C7+L336) (Figure 3B). If the shorter β4 and β5 strands are important for the activating
function of the Src N-lobe, then insertions to lengthen the strands should inactivate Src N-lobe.
Indeed, each insertion decreased the activity of C7 over 90%, indicating that the longer β4 or
β5 strands severely impair the function of the N-lobe of Src.
The crucial role of the shorter β4 and β5 strands for the Src N-lobe raises the question why
Csk has the longer β4 and β5 strands. We tested if the longer β4 and β5 are essential for the
activation of full-length Csk (Figure 3C). Double deletion of I255 and L262 in full length Csk
resulted in a decrease in kinase activity from 54 to 1.3 min−1, confirming that the longer β4
and β5 strands are essential for the activation of full-length Csk. In the full-length Csk structure,
the β-4.5 turn directly interacts with an α-helix from the SH2 domain, and the shorter β4 and
β5 would likely disable this interaction, abolishing the activation of Csk by the SH2 domain.
Indeed mutation of the residue from the SH2 domain α-helix, E154A, in full length Csk also
abolishes Csk activity (18). These results collectively indicate that the interaction between
β-4.5 turn and the SH2 domain in Csk is important for the activation of Csk. Together, the
above analysis indicates that the β-4.5 turn is a crucial structure for the regulation of both Src
and Csk, but plays distinct roles in these two enzymes.
An intriguing observation from the previous section was that C2.4 was even more active than
C7 (Figure 3B). This was surprising because the less active C7 contains the whole Src N-lobe,
while C2.4 is similar to C7 with four N-lobe residues replaced by the Csk counterparts. The
four residues in C7, E320, K321, Y326 and A327, are replaced by Ser, Asn, Leu and Gly,
respectively in C2.4. E320 and K321 are located in the loop connecting the α-helix C and β-4,
while Y326 and A327 are located in the middle of β-4. This suggests that some of these four
Src residues might suppress the kinase activity in Src. To test this hypothesis, two sets of
mutants were constructed (Table 1). First these four residues in C7 were individually mutated
into the Csk counterparts. Three of these mutations activated C7, indicating that these residues
indeed suppress Src activity. As an independent test for this conclusion, the four equivalent
Csk residues in C2.1 were mutated to the Src residues (Table 1). In all cases the activity
significantly decreased, indicating that the Csk residues at these four positions were positive
for the kinase activity. These results indicate that even though the N-lobe of Src activates a
catalytic domain, it also contains inhibitory residues. Further research is needed to ascertain
the suppressive mechanism implicated by these observations.
Region 2: the role of the α-helix C
Region 2 includes the α-helix C and a loop N-terminal to the α-helix C (C-loop). In numerous
tertiary structures of various protein kinases, including PTKs and protein Ser/Thr kinases, the
conformation of the α-helix C closely correlates to the activity of a kinase (35). When the α-
helix C moves closer to the active site, a universally conserved Glu in α-helix C forms a salt
bridge with a universally conserved Lys in the active site. This salt bridge is a ubiquitous
conformational signature of an active kinase. Thus it is not surprising that the α-helix C region
plays an important role in the activation of the Src catalytic domain. The crucial question is
what structural features in the α-helix C region contribute to the regulatory differences in Csk
and Src.
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Two structural features in this region differ in Src and Csk. First, the C-loop contains five
residues in Src (P209-S303) and four residues in Csk (N226-T229), and the two C-loops share
no sequence homology (Figures 1 and 4A). In addition, the first two residues, in the α-helix C
are also different in Src (P304 and E305) and Csk (A230 and Q231). In the tertiary structure
of Src, this loop interacts with the β-4.5 turn. In contrast, the Csk C-loop interacts with an α-
helix from the SH2 domain. To test the importance of C-loop in Src, the five residues in C-
loop and the first two residues in the α-helix C in C7 as a block were mutated to the
corresponding Csk residues (PGTMSPE to NDATAQ, the mutant is named C7-C-loop) (Figure
4A). The activity decreased to approximately 20 min−1 from 170 min−1 (Figure 4B). This
suggests that these residues may play a significant regulatory role, but are not structurally or
catalytically essential. The activity of C7-C-loop is similar to the C2 mutant that differs from
C7 in the β-4.5 turn, while C7 contains a Src β-4.5 turn, C2 contains a Csk β-4.5 turn.
Considering that the C-loop directly interacts with the β-4.5 turn, and mutating either motif
has similar effect on the kinase activity, it appears that that the interaction between C-loop and
β-4.5 turn activates the kinase. The C-loop of Csk has been previously tested by mutagenesis
(18). Mutations of K225, D227 and T229 in the Csk C-loop to Ala cause severe losses of
activity consistent with removing the regulatory SH2 domains, indicating that the interaction
of this region with the SH2 domain is especially important for the function of Csk. Taken
together, these results suggest that the C-loops are important motifs for the regulation of both
Src and Csk, but they play different roles in the regulation.
The second difference between Src and Csk in region 2 is the α-helix C. While the α-helix C
is largely conserved between Csk and Src, the two α-helixes differ by four residues in addition
to the two N-terminal residues. The Src α-helix C contains Q309, Q312, K315 and K316, while
the Csk α-helix C contains A235, S238, T241 and Q242 at the corresponding positions (Figure
4A). Two of these Csk residues, T241 and Q242, form hydrogen bonds with the peptide
backbone of the linker between the SH3 and the SH2 domains in full length Csk (23). These
structural observations provide clues to the different roles of the α-helix C in Csk and Src. To
test the functional importance of the sequence variation in the α-helix C, Q309, Q312, K315
and K316 in C7 were mutated into the equivalent residues in Csk (Ala, Ser, Thr and Gln,
respectively, the mutant is referred to as C7 QQKK in Figure 4B). This mutant displays a kinase
activity level of approximately 35 min−1, indicating that these residues are also important for
the activation of Src activity. These results indicate that the Src-specific residues play important
roles for the activation of Src. We next tested if the interactions of the α-helix C residues with
the SH3-SH2 linker were important for the Csk activity. The mutations of T241 or Q242 to
Ala decreased the activities to 1 and 7 min−1, respectively from the activity of more than 50
min−1 for the full-length Csk (Figure 4C). These results indicate that the interactions between
the α-helix C and the SH2-SH3 linker are important for Csk activation. Taken together, this
mutational analysis indicates that the α-helix C region in Csk and Src have acquired distinct
functionalities suited for the specific regulation of each kinase.
Region 1: R264 is an important residue for Src activation by interacting with β-4.5 turn
We next examined the contribution by region 1. This region appeared to be essential for the
ability of Src N-lobe to activate Csk based on our initial walking data (Figure 2). The C7
construct contains 12 residues N-terminal to the start (W260) of the catalytic domain. We first
deleted these 12 residues (S248-A259), resulting in C8 (Figure 2). C8 displayed a kinase
activity of 84 ± 12 min−1, about half of that of C7 (Figure 2). Ala scanning was performed on
the region 1 residues (W260 through S266) in C8 that are different from those in Csk. The
mutation of R264A had the most effect among these mutants in decreasing the kinase activity
of the Src-Csk chimera (Figure 5B). An examination of the Src crystal structure indicates that
R264 points to the β-4.5 turn (10,27), and forms hydrogen bonds with the peptide backbone
oxygens of E331 and P333, and a side chain oxygen of E331 (Figure 5C). Both E331 and P333
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are located in the β-4.5 turn. Both the structural and mutagenic data support the notion that
R264 is involved in activating Src by its interaction with the β-4.5 turn. Indeed, Abl, whose
catalytic domain alone is active, also contains an Arg residue (R239) at the position equivalent
to R264 of Src. R239 of Abl also forms hydrogen bonds with the backbone oxygens of two
residues from the β-4.5 turn, E308 and P310. These residues are equivalent to E331 and P333
of Src. In contrast, the catalytic domains that are not active in the absence of the regulatory
domains, Csk and Fps, do not contain an Arg residue at the equivalent position. These results
and correlations further support the notion that the interaction between R264 and β-4.5 turn
are important for an active catalytic domain.
Acquisition of the Src structural elements from the N-lobe activates the catalytic domain of
Csk
The above analysis identified three regulatory structural motifs that are crucial for the activating
role of the Src N-lobe: the β-4.5 turn, the α-helix C region, and R264. To test if these elements
are sufficient for the activation of a catalytic domain, we grafted various combinations of these
motifs from Src to the Csk catalytic domain and analyzed what combination would be sufficient
to activate the Csk catalytic domain. Grafting any one of these three structural elements
individually or any combination of two did not activate the Csk catalytic domain (Figure 6).
However, the combination of the double deletion of I255 and L262, M129R point mutation,
and the transfer of the α-helix C region resulted in a significant activation of Csk catalytic
domain (Figure 6, C0.9). It is interesting to note that the precise sequence of the β-4.5 turn
appears insignificant for the activation of the Csk catalytic domain, as indicated by the
comparable kinase activities of C0.7 and C0.9. These two constructs differ only in the β-4.5
turn, while C0.7 contains the original Csk β-4.5 turn, C0.9 contains the Src α-4.5 turn. A
comparison between C0.8 and C0.9 indicates that the Src α-helix C is also necessary for the
activation, even though the Src and Csk α-helix C’s differ by only four residues (Q, Q, K, and
K in Src versus A, S, T, and Q in Csk).
The above analysis of the kinase activity of various mutants has used polyE4Y as a substrate.
PolyE4Y is a commercial random copolymer of Glu and Tyr in the ratio of 4:1, and contains
a mixture of ill-defined phosphorylation sites. While phosphorylation of polyE4Y provides a
convenient way to measure the kinase activity, its interaction with Csk does not represent the
docking-based recognition between Csk and Src (29–32). Thus, we wanted to test if the
artificially activated Csk catalytic domain could phosphorylate the physiological substrate of
Csk, Src (a kinase defective version of Src, kdSrc, was used) (Table 2). C0.9 displayed a kcat
of 136 min−1 and a Km of 30 μM. The Km value is somewhat higher than those of the full-
length and the catalytic domain of Csk, but roughly comparable. The kcat is approximately 160-
fold higher than that of the catalytic domain of Csk (C0 in Table 2), and comparable to that of
full length Csk. These results demonstrate that not only the catalytic domain of Csk is activated
by the grafted structural elements from Src, it also retains the ability to specifically
phosphorylate its physiological substrate. This is consistent with the finding that the site of
substrate recognition of Csk is located in the C-lobe of the catalytic domain (29–32).
Discussion
Protein kinases, containing more than 500 members, represent the largest family of enzymes
in the human proteome (36). All protein kinases catalyze a similar reaction, the phosphorylation
of proteins on Tyr, Ser, or Thr residues. Yet each kinase plays a specific role in cellular
signaling, due to its individual substrate specificity and the spectrum of regulatory signals each
kinase responds to. Each kinase evolutionarily acquires unique structural elements that confer
unique substrate specificity and regulation without compromising the general catalytic
machinery. Identifying and understanding the functional implications of the structural motifs
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are important for understanding signaling by kinases. In this study, we focused on identifying
unique structural elements that dictate the kinase activity levels of the Csk and Src catalytic
domains, which dictate their regulatory strategies.
The catalytic activity of a kinase can be determined at three levels: substrate recognition,
catalysis or regulation. Substrate recognition plays a major role in restricting the catalytic
activity of Csk toward certain substrates. While Csk is efficient in phosphorylating Src family
kinases, such as Src and Lck, it displays approximately 50,000 fold less activity toward small
peptides mimicking the phosphorylation site of these protein substrates (37). Even toward
optimized consensus peptide substrate for Csk, the Km is still more than 100 times higher than
the protein substrates. Two reasons account for this deficiency in Csk activity toward peptide
substrates. First, Csk recognition of Src family proteins relies on extensive remote docking
interactions a peptides substrate cannot fulfill (29–32). Second, Csk has a shorter activation
loop than other kinases, which disrupts the anchoring of peptide substrates (32). The
combination of these two mechanisms restricts Csk substrates to those that can be positioned
for phosphorylation through extensive docking interactions. PolyE4Y is an excellent substrate
for Csk most likely for the same reason, even though the specific interactions between Csk and
polyE4Y have not been identified. However, the lack of activity by the Csk catalytic domain
is not likely solely due to a lack of substrate recognition, as the catalytic domain of Csk contains
all the substrate-docking motifs and is fully capable of recognizing Src protein as a substrate
(32). Furthermore, the Csk catalytic domain also contains all the catalytically important
residues, thus the lack of activity by the Csk catalytic domain is likely due to a conformational
rather than a primary structural defect. Based on these considerations, we hypothesized that
the lack of kinase activity by the catalytic domain of Csk is either the result of missing
regulatory mechanisms that maintain an active conformation, or inhibitory motifs that keep
Csk catalytic domain at an inactive conformation.
Previously we have identified the N-lobe of the catalytic domain to be responsible for
controlling the kinase activity of Csk and Src (34). In this current study, we conducted an
extensive dissection of the Src and Csk N-lobe to identify the responsible structural elements.
Using a structure-guided grafting approach, we identified three important motifs in the N-lobe
that differ structurally in Src and Csk and play distinct roles in their regulation: the α-helix C
region, the β-4.5 turn and R264 in Src. These motifs and their interactions are highly divergent
in Src and Csk. In the Src structure, the β-4.5 turn interacts with R264 on one side and the C-
loop on the other (Figure 7A). Mutation to any of these elements would disable the activating
function of the Src N-lobe. It is likely that the interactions among these motifs collectively
dictate the conformation of the α-helix C and the active site residues to result in an active
catalytic domain. In contrast, the equivalent motifs in Csk are different in primary structure
from those of Src, and they do not have interactions similar to those in Src (Figure 7B). First,
the β-4 and β-5 strands are longer in Csk, sending the β-4.5 turn further out. Furthermore, Csk
contains a Met residue at the position equivalent to the R264 in Src, thus the interaction between
the β-4.5 turn and the Arg residue is not present. Second, the combination of changes in the
β-4.5 turn and the C-loop region also disables the interaction between the turn and the loop in
Csk. Thus, the interactions that are important for the activating function of the Src N-lobe are
not present in Csk, resulting in an inactive Csk catalytic domain. Indeed, the signature
interactions and conformations of an active kinase, such as the conformation of the DFG motif
and the salt bridge between Glu236 and Lys222 are not observed in the catalytic domain of
Csk (24). The unique structures of the identified motifs in Csk also appear to set up the
activating interactions with the regulatory SH2 domain, as if some of the activating
functionalities in Src catalytic domain are transferred to the regulatory domain in Csk. First,
the longer β-4 and β-5 strands send the β-4.5 turn further to directly interact with an α-helix in
the SH2 domain (α-SH2 in Figure 7B). Second, the C-loop also directly interacts with the α-
SH2. Third, the α-helix C in Csk has acquired residues that directly interact with the linker
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between the SH3 and the SH2 domains. Data presented in this and a previous study (18)
demonstrates that each of these observed interactions is important for the activation of full-
length Csk. These analyses provide a model for the differential regulations of Csk and Src by
domain-domain interactions. It is as if the Src N-lobe contains a fully functional “ON” switch,
and the Csk N-lobe contains an incomplete “ON” switch that needs to be complemented by
certain structural elements from the regulatory domain for Csk activation.
The most compelling evidence for the correct functional assignment of these motifs is that
grafting these structural elements from Src to the catalytic domain of Csk results in an active
Csk catalytic domain, while missing any of these elements would result in an inactive catalytic
domain. This result indicates that the interactions among these structural elements are indeed
sufficient to activate an otherwise inactive catalytic domain. It is unlikely that any catalytic
functionality is gained from such grafting, as the Csk catalytic domain is capable of being
active when properly activated. We speculate that correct positioning of the α-helix C is likely
the key consequence of these grafted interactions.
It is not clear how the interactions that activate the Src catalytic domain are related to the
inactivation of Src. Src is inactivated by phosphorylation of a C-terminal Tyr residue, Tyr527
(9,10). The phosphorylated Tyr527 binds to the SH2 domain, which leads to interactions
between the SH3 domain and the SH2-catalytic domain linker (6). Because the identified motifs
and their interactions are the key to the Src activation, any conformational changes that disrupt
these interactions could result in Src inactivation. Thus, it is conceivable that the binding
between phospho-Tyr527 to the SH2 domain may lead to disruption of the activating
interactions among the identified motifs. A comparison of the active and inactive Src structures
does not reveal any major differences in the conformations and interactions of these motifs.
Alternatively, there may be a separate mechanism that disrupts the active conformation. It is
interesting to note that the mutation of several residues activates Src, suggesting that these
residues may be involved in suppressing Src kinase activity (Table 1). Further investigation is
required to determine the detailed mechanisms of Src inactivation.
The regulation model developed in this study may apply to other protein tyrosine kinases or
protein kinases in general. Accumulating evidence indicates that the N-lobe is a crucial region
that determines the regulation of protein kinases (33,34). Molecular dynamics free energy
calculations indicate that the N-terminal end of the catalytic domain of Hck is a conformational
switch in the allosteric regulation, although the structural basis for the conformational switch
is not determined (33). Several structural studies also point to the same surface area in the N-
lobe as key regulatory structures in other protein kinases. For example, similar to the catalytic
domain of Csk, all cyclin-dependent kinases contain a catalytic domain that is inactive by itself.
Activation is achieved by the binding to a cyclin molecule among other events (38). Among
other interactions, the cyclin directly interacts with the β-4.5 turn, the C-loop, and the α-helix
C of the cyclin-dependent kinase 2 (39, PDB ID: 1JTS). This regulation is highly analogous
to the activating interaction between the Csk catalytic domain and the regulatory domains.
Another example is the receptor-type protein tyrosine kinase EGFR, which is activated by the
formation of an asymmetric homodimer between two EGFR molecules (40). In the asymmetric
dimer, the C-terminal lobe of one kinase domain binds to the β-4.5 turn, C-loop and the α-helix
C region of another kinase molecule, analogous to that of cyclin in activated CDK/cyclin
complexes. In a recently published structure of v-Fps (3), in which the catalytic domain is
activated by the SH2 domain, the SH2 domain also interacts with the α-helix C and the β-4.5
turn region in a way generally similar to that in Csk. These structural observations suggest that
β-4.5 turn and its interactions with the C-loop and other motifs may be a focal point of
regulatory interactions in many different protein kinases.
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Materials and Methods
Reagents and chemicals
All reagents used for bacterial culture and protein expression were purchased from Fisher. The
chromatographic resin, iminodiacetic acid-Agarose, was purchased from Sigma, Amylose-
Agarose was purchased from New England Biolabs. DNA primers were synthesized by
Integrated DNA Technologies. [γ-32P]ATP (6,000 Ci mol−1) was purchased from PerkinElmer.
Plasmid construction and protein expression
Src mutants were expressed as a fusion protein with maltose-binding protein (MBP) using
pMAL-c2x expression vector (New England Biolabs) or as (His)6-tagged protein using the
pRSET-a vector as indicated. The MBP fusion proteins were purified as described previously
(41). The (His)6-tagged Src mutants from the pRSET plasmids were coexpressed with GroES/
EL chaperone (pREP4groESL) and protein tyrosine phosphatase 1B (pPCDF-PTP1B). The
chaperone helps with the correct folding and increases the solubility of the protein, and the
PTP 1B helps reduce toxicity due to Src overexpression. The (His)6-fusion proteins were
purified using immobilized Ni2+-iminodiacetic acid-Agarose as described previously (29).
Mutant plasmids were constructed using Quikchange from Stratagene, and confirmed by DNA
sequencing. Upon confirmation, the plasmids were transformed into appropriate host E. coli
cells for protein expression and purification. After each mutant enzyme was obtained, the
concentration and purity of the enzyme was determined by Bradford assay and SDS-PAGE,
respectively. The purified proteins were stored in 50% glycerol and 25 mM Tris, pH 8.0 at −20
°C.
Kinase assays
For quantifying PTK activities, we measured the phosphorylation of polyE4Y or kdSrc (kinase-
defective Src) using the acid precipitation assay (31). PolyE4Y is a random copolymer of Glu
and Tyr in the ratio of 4:1 (Sigma). A standard assay reaction of 50 μl contained the kinase
and the substrates (1 mg ml−1 polyE4Y, and 200 μM 32P-ATP [~1,000 dpm/pmol]) in the
kinase assay buffer (75 mM 4-(2-hydroxyethyl)piperazine-1-propanesulfonic acid [EPPS], pH
8.0, 12 mM MgCl2, 5% glycerol, 0.005% Triton X-100). After the reaction at 30°C for 30 min,
35 μl reaction mixtures were spotted onto filter paper strips (1×2 cm), which were then washed
in 5% trichloroacetic acid at approximately 65°C 3-times for approximately 10 min each.
Phosphorylated and unphosphorylated polyE4Y was precipitated onto the filter paper and the
amount of phosphate incorporated into polyE4Y on the filter paper was determined by liquid
scintillation counting. For each mutant enzyme, the activity was first determined at a series of
enzyme concentrations to find the concentration range that gave a reasonable signal and a linear
relationship between the signal and the enzyme concentration. Then the activity was
determined at least three times using enzyme concentrations in the linear range. The specific
activity of a mutant enzyme, expressed as the mole of phosphate transferred by each mole of
enzyme within a min (min−1) under the standard assay conditions, was calculated from each
determination. The average activity and the standard error were calculated from at least three
such determinations for each mutant enzyme.
A kinase-defective mutant of Src (kdSrc) was used as a substrate to determine the ability of
certain mutants to phosphorylate a physiological substrate of Csk. KdSrc differs from the active
Src by only a single residue substitution (K295M), and retains the structural and functional
specificity as a substrate for Csk. KdSrc was prepared as described previously (29). The level
of kdSrc phosphorylation was determined as described for polyE4Y phosphorylation above
except the concentration of kdSrc used was 10 μM. To determine the steady state kinetic
parameters of Csk and mutants phosphorylating kdSrc, a range of kdSrc concentrations (2–10
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μM) were used, and the kcat and Km values were calculated by Lineweaver-Burk plot. The
reported values were based on three independent determinations.
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Figure 1. Primary and secondary structures of the kinase N-lobe
A. Alignment of the amino acid sequences of the N-lobes of the catalytic domains of Csk and
Src. The Csk residue numbering and the Src residue numbering are indicated above and below
the sequences, respectively. The secondary structures of the Src N-lobe are indicated at the
bottom of the illustration. The three motifs of particular interest to this study are colored green.
B. A ribbon structure of the N-lobe of Src catalytic domain with all relevant secondary
structures indicated. The residue R264 is also shown.
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Figure 2. Chimeric walking to identify important regions of the Src N-lobe for its activating function
A. The ribbon structure of the Src N-lobe. The joining residues of various constructs in B are
indicated by the residue numbers. B. Chimeric constructs of Csk and Src catalytic domains.
The black bars represent the portions of the Src catalytic domain and the white bars represent
the portions of the Csk catalytic domain. The residues numbers indicate the starting and ending
residues of the Src portions that replace the counterparts of Csk. The kinase activities with
standard errors refer to the specific activity (min−1) under standard assay conditions as defined
in Materials and Methods. The reported values are calculated from at least three independent
determinations. For reference, full-length Src and Csk have kcat values of 260 ± 10 min−1 and
150 ± 27 min−1, respectively, with ATP as the variable substrate at 1 mg ml−1 polyE4Y (34).
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Figure 3. Dissection of region 3
A. Illustration of the region and residue studied in region 3, i.e., the β-4.5 turn region. B. Kinase
mutants based on C2 and C7 from Figure 2 were generated to determine what structural features
of the region 3 are important for the activating function of the Src-N-lobe. A “+” in front of
residue indicates an insertion and a “Δ” indicates a deletion. Otherwise the indicated mutation
is a substitution of the Src motif for the Csk counterpart. C. Kinase activity of full-length Csk
and a Csk mutant that contains a double deletion of I255 and L262 (Csk DD).
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Figure 4. Effects of mutations in the α-helix C region in chimeric kinase C7 and full-length Csk
A. Diagram showing the Src residues studied in this experiment. PGTMSPE were mutated in
block to the Csk counterparts, NDATAQ, in C7 C-loop, while four Src residues (Q309, Q312,
K315 and K316) on the α-helix C in C7 were mutated to Csk residues (A, S, T, and M,
respectively) (C7 QQKK). B. Effects of the mutations on the kinase activity of C7. C. Unique
residues in the α-helix C of full-length Csk were individually mutated to Ala, and the effects
of these mutations were determined.
Huang et al. Page 16
J Mol Biol. Author manuscript; available in PMC 2010 March 6.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 5. The kinase activity of Ala scanning mutants in region 1
A. The N-lobe of Src catalytic domain. The seven-residue fragment, W260 through S266
studied in this experiment is indicated. B. The kinase activity of Src-Csk chimeric kinase C8
and designated Ala scanning mutants based on C8 are shown. All the activities are expressed
as a percentage of that of C8. C. Interaction between R264 and the β-4.5 turn by four hydrogen
bonds.
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Figure 6. Grafting of various Src N-lobe structural motifs to the catalytic domain of Csk
Various Src motifs, and their combinations were grafted to the catalytic domain of Csk to
determine if any motifs individually or in combination can activate the Csk catalytic domain.
DD, double deletion of I255 and L262; M129R, M129 of catalytic domain mutated to R. Other
motifs (C-loop, α-C, β-4.5 turn) are as indicated in Figure 1.
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Figure 7. Ribbon structures of the N-lobes of Src and Csk and their interactions
A. The structure of the N-lobe of Src. The identified motifs that are important in activating the
Src catalytic domain are indicated. B. The structure of the N-lobe of Csk. In addition to the N-
lobe motifs, the SH2 domain is also shown to illustrate the interaction between the SH2 domain
and the N-lobe.
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Table 1
The function of several residues in region three on the kinase activity of C7 and C2.1
On the left, several indicated residues in C7 were individually mutated from the Src residue to their Csk
counterparts. On the right, the equivalent Csk residues were individually mutated to the Src counterparts.
Src to Csk mutation Kinase activity (min−1) Csk to Src mutation Kinase activity (min−1)
C7 170 ± 3 C2.1 13 ± 0.5
C7.E320S 228 ± 3.3 C2.1.S246E 2.1 ± 0.2
C7.K321N 210 ± 1.4 C2.1.N247K 4.5 ± 0.1
C7.Y326L 346 ± 3.2 C2.1.L252Y 1 ± 0.6
C7.A327G 177 ± 1.2 C2.1.G253A 0.4 ± 0.005
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Table 2
Catalytic parameters of full-length Csk (Csk), the catalytic domain of Csk (C0) and the
catalytic domain of Csk with Src structural elements (C0.9)
The catalytic parameters of Csk and mutants using kdSrc as a variable substrate (2–10 μM) and ATP as a fixed
substrate (0.2 mM) were determined as described in Materials and Methods. C0 refers to the catalytic domain of
Csk, and C0.9 refers to the catalytic domain of Csk with all grafted Src elements (DD+M192R+C-loop+α-C
+β-4.5 turn) as shown in Figure 6.
Enzyme kcat (min
−1) Km for kdSrc (μM)
Csk 113 ± 23 10 ± 0.5
C0 0.84 ± 0.3 8.3 ± 3
C0.9 136 ± 14.8 30 ± 8.6
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